Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1186279010 | Irbesartan+hydrochlorothiazide 300mg/12.5mg tablet (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 216264017 | Irbesartan+hydrochlorothiazide 300mg/12.5mg tablet | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 2693300012 | Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablet | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3483111015 | Product containing irbesartan 300 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3491467010 | Product containing irbesartan 300 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3500087017 | Irbesartan 300 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3559355013 | Product containing only irbesartan 300 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3559356014 | Product containing only irbesartan 300 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3679877015 | Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3679878013 | Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3679879017 | Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 514037015 | Irbesartan+hydrochlorothiazide 300mg/12.5mg tablet (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Is a | Hydrochlorothiazide and irbesartan only product in oral dose form | true | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Is a | Irbesartan-containing product | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has active ingredient | Diuretic | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has active ingredient | Irbesartan | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Is a | Hydrochlorothiazide- and irbesartan-containing product | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Is a | Angiotensin II receptor antagonist+diuretic | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Is a | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has BoSS | Hydrochlorothiazide | false | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has active ingredient | Irbesartan | false | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has BoSS | Irbesartan | false | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has BoSS | Irbesartan | true | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength numerator value | 300 | false | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has BoSS | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has active ingredient | Irbesartan | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has precise active ingredient | Irbesartan | true | Inferred relationship | Some | 1 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Some | 2 | |
| Hydrochlorothiazide 12.5 mg and irbesartan 300 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR